{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:32:53Z","timestamp":1759365173517,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ajic.2014.01.004","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T16:25:27Z","timestamp":1398443127000},"page":"546-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of the Cystic Fibrosis Foundation's extensive sputum-culturing protocol for patients without cystic fibrosis: Implications for infection control and antimicrobial resistance"],"prefix":"10.1016","volume":"42","author":[{"given":"Jennifer","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2014.01.004_bib1","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1086\/503485","article-title":"Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission","volume":"24","author":"Saiman","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2014.01.004_bib2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ajic.2014.01.004_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/MCP.0b013e328312ed8c","article-title":"Update on non-cystic fibrosis bronchiectasis","volume":"14","author":"Bilton","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"Suppl 1","key":"10.1016\/j.ajic.2014.01.004_bib4","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.ajic.2014.01.004_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2012-203105","article-title":"Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition","volume":"68","author":"Rogers","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.ajic.2014.01.004_bib6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/jac\/dkp007","article-title":"Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis","volume":"63","author":"Gillham","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2014.01.004_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1378\/chest.10-0099","article-title":"Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006","volume":"138","author":"Seitz","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ajic.2014.01.004_bib8","first-page":"CD001392","article-title":"Prolonged antibiotics for purulent bronchiectasis in children and adults","author":"Evans","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajic.2014.01.004_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ppul.21198","article-title":"Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008","volume":"45","author":"Emerson","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ajic.2014.01.004_bib10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1378\/chest.123.5.1495","article-title":"Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis","volume":"123","author":"Smith","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ajic.2014.01.004_bib11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1128\/JCM.44.4.1547-1549.2006","article-title":"Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis","volume":"44","author":"Zhou","year":"2006","journal-title":"J\u00a0Clin Microbiol"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655314000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655314000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:40:07Z","timestamp":1759297207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655314000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0196655314000054"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2014.01.004","relation":{},"ISSN":["0196-6553"],"issn-type":[{"type":"print","value":"0196-6553"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of the Cystic Fibrosis Foundation's extensive sputum-culturing protocol for patients without cystic fibrosis: Implications for infection control and antimicrobial resistance","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2014.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}